Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors

Since target therapy with mTOR inhibitors plays an important role in the current management of clear cell renal cell carcinoma (RCC), there is an increasing demand for predictive biomarkers, which may help to select patients that are most likely to benefit from personalized treatment. When dealing w...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Am J Cancer Res
Main Authors: Fiorini, Claudia, Massari, Francesco, Pedron, Serena, Sanavio, Sara, Ciccarese, Chiara, Porcaro, Antonio Benito, Artibani, Walter, Bertoldo, Francesco, Zampini, Claudia, Sava, Teodoro, Ficial, Miriam, Caliò, Anna, Chilosi, Marco, D’Amuri, Alessandro, Sanguedolce, Francesca, Tortora, Giampaolo, Scarpa, Aldo, Delahunt, Brett, Porta, Camillo, Martignoni, Guido, Brunelli, Matteo
פורמט: Artigo
שפה:Inglês
יצא לאור: e-Century Publishing Corporation 2014
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266722/
https://ncbi.nlm.nih.gov/pubmed/25520878
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים